SEARCH

SEARCH BY CITATION

References

  • Afdhal, N., McHutchison, J., Brown, R., Jacobson, I., Manns, M., Poordad, F., Weksler, B. & Esteban, R. (2008) Thrombocytopenia associated with chronic liver disease. Journal of Hepatology, 48, 10001007.
  • Agarwal, S., Joyner, K.A. & Swaim, M.W. (2000) Ascitic fluid as a possible origin for hyperfibrinolysis in advanced liver disease. American Journal of Gastroenterology, 95, 32183224.
    Direct Link:
  • Amitrano, L., Guardascione, M.A., Brancaccio, V., Balzano, A., Amitrano, L., Guardascione, M.A., Brancaccio, V. & Balzano, A. (2002) Coagulation disorders in liver disease. Seminars in Liver Disease, 22, 8396.
  • Anstee, Q.M., Wright, M., Goldin, R., Thursz, M.R., Anstee, Q.M., Wright, M., Goldin, R. & Thursz, M.R. (2009) Parenchymal extinction: coagulation and hepatic fibrogenesis. Clinics in Liver Disease, 13, 117126.
  • Ballard, H.S. (1989) Hematological complications of alcoholism. Alcoholism, Clinical and Experimental Research, 13, 706720.
  • Baxter, E.J., Scott, L.M., Campbell, P.J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G.S., Bench, A.J., Boyd, E.M., Curtin, N., Scott, M.A., Erber, W.N., Green, A.R., Cancer Genome, P., Baxter, E.J., Scott, L.M., Campbell, P.J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G.S., Bench, A.J., Boyd, E.M., Curtin, N., Scott, M.A., Erber, W.N. & Green, A.R. (2005) Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet, 365, 10541061. [erratum appears in Lancet. 2005 Jul 9-15;366(9480):122].
  • Bellest, L., Eschwège, V., Poupon, R., Chazouillères, O. & Robert, A. (2007) A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology. Hepatology, 46, 528534.
  • Ben-Ari, Z., Panagou, M., Patch, D., Bates, S., Osman, E., Pasi, J. & Burroughs, A. (1997) Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. Journal of Hepatology, 26, 554559.
  • Bernard, B., Grangé, J.-D., Khac, E.N., Amiot, X., Opolon, P. & Poynard, T. (1999) Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology, 29, 16551661.
  • Bismuth, H., Ericzon, B.G., Rolles, K., Castaing, D., Otte, J.B. & Ringe, B. (1987) Hepatic transplantation in Europe: first report of the European Liver Transplant Registry. Lancet, 330, 674676.
  • Bleichner, G., Boulanger, R., Squara, P., Sollet, J.P. & Parent, A. (1986) Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage. British Journal of Surgery, 73, 724726.
  • De Boer, M.T., Molenaar, I.Q., Hendriks, H.G., Slooff, M.J., Porte, R.J., De Boer, M.T., Molenaar, I.Q., Hendriks, H.G.D., Slooff, M.J.H. & Porte, R.J. (2005) Minimizing blood loss in liver transplantation: progress through research and evolution of techniques. Digestive Surgery, 22, 265275.
  • Bontempo, F.A., Lewis, J.H., Van Thiel, D.H., Spero, J.A., Ragni, M.V., Butler, P., Israel, L. & Starzl, T.E. (1985) The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation, 39, 532536.
  • Bosch, J., Thabut, D., Bendtsen, F., D’Amico, G., Albillos, A., González Abraldes, J., Fabricius, S., Erhardtsen, E. & De Franchis, R. (2004) Recombinant factor VIIa for upper gastrointestinal bleeding in patients with cirrhosis: a randomized, double-blind trial. Gastroenterology, 127, 11231130.
  • Boylan, J.F., Klinck, J.R., Sandler, A.N., Arellano, R., Greig, P.D., Nierenberg, H., Roger, S.L. & Glynn, M.F.X. (1996) Tranexamic Acid Reduces Blood Loss, Transfusion Requirements, and Coagulation Factor Use in Primary Orthotopic Liver Transplantation. Anesthesiology, 85, 10431048.
  • British Committee for Standards in Haematology & Blood Transfusion Taskforce (2003) Guidelines for the use of platelet transfusions. British Journal of Haematology, 122, 1023.
  • British Committee for Standards in Haematology & Blood Transfusion Taskforce (2004) Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. British Journal of Haematology, 126, 1128.
  • Cacciarelli, T.V., Keeffe, E.B., Moore, D.H., Burns, W., Chuljian, P., Busque, S., Concepcion, W., So, S.K.S. & Esquivel, C.O. (1996) Primary liver transplantation without transfusion of red blood cells. Surgery, 120, 698705.
  • Caldwell, S.H., Hoffman, M., Lisman, T., Macik, B.G., Northup, P.G., Reddy, K.R., Tripodi, A. & Sanyal, A.J., Group CiLD (2006) Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology 44: 10391046.
  • Calvaruso, V., Maimone, S., Gatt, A., Tuddenham, E., Thursz, M., Pinzani, M. & Burroughs, A.K. (2008) Coagulation and fibrosis in chronic liver disease. Gut, 57, 17221727.
  • Carr, J.M. (1989) Disseminated intravascular coagulation in cirrhosis. Hepatology, 10, 103110.
  • Chau, T.N., Chan, Y.W., Patch, D., Tokunaga, S., Greenslade, L. & Burroughs, A.K. (1998) Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding. Gut, 43, 267271.
  • Colaizzo, D., Amitrano, L., Tiscia, G.L., Scenna, G., Grandone, E., Guardascione, M.A., Brancaccio, V. & Margaglione, M. (2007) The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis. Journal of Thrombosis and Haemostasis, 5, 5561.
  • Condat, B. & Valla, D. (2006) Nonmalignant portal vein thrombosis in adults. Nature Clinical Practice. Gastroenterology & Hepatology, 3, 505515.
  • Condat, B., Pessione, F., Hillaire, S., Denninger, M.-H., Guillin, M.-C., Poliquin, M., Hadengue, A., Erlinger, S. & Valla, D. (2001) Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy. Gastroenterology, 120, 490497.
  • Dalmau, A., Sabate, A., Koo, M., Bartolome, C., Rafecas, A., Figueras, J. & Jaurrieta, E. (2004) The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study.[see comment]. Liver Transplantation, 10, 279284.
  • Davenport, A., Will, E.J. & Davison, A.M. (1994) Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure. Nephron, 66, 431437.
  • DeLeve, L.D., Valla, D.C., Garcia-Tsao, G. & American Association for the Study Liver Diseases (2009) Vascular disorders of the liver. Hepatology, 49, 17291764.
  • Denninger, M.-H., Chaït, Y., Casadevall, N., Hillaire, S., Guillin, M.-C., Bezeaud, A., Erlinger, S., Briere, J. & Valla, D. (2000) Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology, 31, 587591.
  • Dentali, F., Squizzato, A., Brivio, L., Appio, L., Campiotti, L., Crowther, M., Grandi, A.M. & Ageno, W. (2009) JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. Blood, 113, 56175623.
  • Dethloff, T., Tofteng, F., Frederiksen, H.J., Hojskov, M., Hansen, B.A. & Larsen, F.S. (2008) Effect of Prometheus liver assist system on systemic hemodynamics in patients with cirrhosis: a randomized controlled study. World Journal of Gastroenterology, 14, 20652071.
  • Detry, O., Deroover, A., Delwaide, J., Delbouille, M.H., Kaba, A., Joris, J., Damas, P., Lamy, M., Honore, P. & Meurisse, M. (2005) Avoiding blood products during liver transplantation. Transplantation Proceedings, 37, 28692870.
  • Durao, M.S., Monte, J.C., Batista, M.C., Oliveira, M., Iizuka, I.J., Santos, B.F., Pereira, V.G., Cendoroglo, M., Santos, O.F., Durao, M.S., Monte, J.C.M., Batista, M.C., Oliveira, M., Iizuka, I.J., Santos, B.F., Pereira, V.G., Cendoroglo, M. & Santos, O.F.P. (2008) The use of regional citrate anticoagulation for continuous venovenous hemodiafiltration in acute kidney injury. Critical Care Medicine, 36, 30243029.
  • Dzik, W., Arkin, C., Jenkins, R. & Stump, D. (1988) Fibrinolysis during liver transplantation in humans: role of tissue- type plasminogen activator. Blood, 71, 10901095.
  • Escolar, G., Cases, A., Vinas, M., Pino, M., Calls, J., Cirera, I. & Ordinas, A. (1999) Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100): influence of hematocrit elevation. Haematologica, 84, 614619.
  • Faeh, M., Hauser, S.P. & Nydegger, U.E. (2001) Transient thrombopoietin peak after liver transplantation for end-stage liver disease. British Journal of Haematology, 112, 493498.
  • Feistauer, S.M., Penner, E., Mayr, W.R. & Panzer, S. (1997) Target platelet antigens of autoantibodies in patients with primary biliary cirrhosis. Hepatology, 25, 13431345.
  • Ferro, D., Quintarelli, C., Lattuada, A., Leo, R., Alessandroni, M., Mannucci, P.M. & Violi, F. (1996) High plasma levels of von Willebrand’s factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxaemia. Hepatology, 23, 13771383.
  • Findlay, J.Y., Rettke, S.R., Ereth, M.H., Plevak, D.J., Krom, R.A.F. & Kufner, R.P. (2001) Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study. Liver Transplantation, 7, 802807.
  • Fisher, N.C. & Mutimer, D.J. (1999) Central venous cannulation in patients with liver disease and coagulopathy – a prosepective audit. Intensive Care Medicine, 25, 164171.
  • De Franchis, R. (2005) Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. Journal of Hepatology, 43, 167176.
  • Franchis, Rd., Arcidiacono, P.G., Carpinelli, L., Andreoni, B., Cestari, L., Brunati, S., Zambelli, A., Battaglia, G. & Mannucci, P.M., Club TNIE (1993) Randomized controlled trial of desmopressin plus terlipressin vs. terlipressin alone for the treatment of acute variceal hemorrhage in cirrhotic patients: a multicenter, double-blind study. Hepatology 18: 11021107.
  • García-Suárez, J., Burgaleta, C., Hernanz, N., Albarran, F., Tobaruela, P. & Alvarez-Mon, M. (2000) HCV-associated thrombocytopenia: clinical characteristics and platelet response after recombinant alpha2b-interferon therapy. British Journal of Haematology, 110, 98103.
  • Hadengue, A., Poliquin, M., Vilgrain, V., Belghiti, J., Degott, C., Erlinger, S. & Benhamou, J.-P. (1994) The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology, 106, 10421047.
  • Hersch, S., Kunelis, T. & Francis, R.J. (1987) The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitor. Blood, 69, 13151319.
  • Hollestelle, M.J., Geertzen, H.G.M., Straatsburg, I.H., Van Gulik, T.M. & Van Mourik, J.A. (2004) Factor VIII expression in liver disease. Thrombosis & Haemostasis, 91, 267275.
  • Hou, M.-C., Lin, H.-C., Liu, T.-T., Kuo, B.I.-T., Lee, F.-Y., Chang, F.-Y. & Lee, S.-D. (2004) Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology, 39, 746753.
  • Hsia, C.C., Chin-Yee, I.H. & McAlister, V.C. (2008) Use of recombinant activated Factor VII in patients without haemophilia: a meta-analysis of randomised controlled trials. Annals of Surgery, 248, 6168.
  • Huber, K., Kirchheimer, J.C., Korninger, C. & Binder, B.R. (1991) Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosis. Thrombosis Research, 62, 491500.
  • Ishitani, M., Angle, J., Bickston, S., Caldwell, S., Isaacs, R. & Pruett, T. (1997) Liver transplantation: incidence and management of deep venous thrombosis and pulmonary emboli. Transplantation Proceedings, 29, 28612863.
  • James, C., Ugo, V., Le Couedic, J.P., Staerk, J., Delhommeau, F., Lacout, C., Garcon, L., Raslova, H., Berger, R., Bennaceur-Griscelli, A., Villeval, J.L., Constantinescu, S.N., Casadevall, N., Vainchenker, W., James, C., Ugo, V., Le Couedic, J.-P., Staerk, J., Delhommeau, F., Lacout, C., Garcon, L., Raslova, H., Berger, R., Bennaceur-Griscelli, A., Villeval, J.L., Constantinescu, S.N., Casadevall, N. & Vainchenker, W. (2005) A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature, 434, 11441148.
  • Janssen, H.L.A., Meinardi, J.R., Vleggaar, F.P., Van Uum, S.H.M., Haagsma, E.B., Van Der Meer, F.J.M., Van Hattum, J., Chamuleau, R.A.F.M., Adang, R.P., Vandenbroucke, J.P., Van Hoek, B. & Rosendaal, F.R. (2000) Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood, 96, 23642368.
  • Janssen, H.L.A., Garcia-Pagan, J.-C., Elias, E., Mentha, G., Hadengue, A. & Valla, D.-C. (2003) Budd-Chiari syndrome: a review by an expert panel. Journal of Hepatology, 38, 364371.
  • Jeffers, L., Chalasani, N., Balart, L., Pyrsopoulos, N. & Erhardtsen, E. (2002) Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy. Gastroenterology, 123, 118126.
  • Joist, J.H. (1999) AICF and DIC in liver cirrhosis: expressions of a hypercoagulable state.[comment]. American Journal of Gastroenterology, 94, 28012803.
    Direct Link:
  • Kamath, P.S., Wiesner, R.H., Malinchoc, M., Kremers, W., Therneau, T.M., Kosberg, C.L., D’Amico, G., Dickson, E.R. & Kim, W.R. (2001) A model to predict survival in patients with end-stage liver disease. Hepatology, 33, 464470.
  • Kang, Y.G.M.D., Martin, D.J.M.D., Marquez, J.M.D., Lewis, J.H.M.D., Bontempo, F.A.M.D., Shaw, B.W.J.M.D., Starzl, T.E.M.D. & Winter, P.M.M.D. (1985) Intraoperative Changes in Blood Coagulation and Thrombelastographic Monitoring in Liver Transplantation. Anesthesia & Analgesia, 64, 888896.
  • Kang, Y.M.D., Lewis, J.H.M.D., Navalgund, A.M.D., Russell, M.W.M.D., Bontempo, F.A.M.D., Niren, L.S.M.D. & Starzl, T.E.M.D.P.D. (1987) Epsilon-aminocaproic Acid for Treatment of Fibrinolysis during Liver Transplantation. Anesthesiology, 66, 758773.
  • Kaspar, M.M.D., Ramsay, M.A.E.M.D., Nguyen, A.-T.M.D., Cogswell, M.M.D., Hurst, G.M.D. & Ramsay, K.J.B.A. (1997) Continuous Small-Dose Tranexamic Acid Reduces Fibrinolysis but not Transfusion Requirements During Orthotopic Liver Transplantation. Anesthesia & Analgesia, 85, 281285.
  • Keeling, D. (2007) International Normalised Ratio in patients not on vitamin K antagonists. Journal of Thrombosis and Haemostasis, 5, 188189.
  • Kerr, R., Newsome, P., Germian, L., Thomson, E., Dawson, P., Stirling, D. & Ludlam, C.A. (2003) Effects of acute liver injury on blood coagulation. Journal of Thrombosis and Haemostasis, 1, 754759.
  • Kettner, S.C.M.D., Gonano, C.M.D., Seebach, F.M.D., Sitzwohl, C.M.D., Acimovic, S.M.D., Stark, J.M.D., Schellongowski, A.M.D., Blaicher, A.M.D., Felfernig, M.M.D. & Zimpfer, M.M.D. (1998) Endogenous Heparin-Like Substances Significantly Impair Coagulation in Patients Undergoing Orthotopic Liver Transplantation. Anesthesia & Analgesia, 86(4), 691695.
  • Kirby, R.M., McMaster, P., Clemens, D., Hubscher, S.G., Angrisani, L., Sealey, M., Gunson, B.K., Salt, P.J., Buckels, J.A.C., Adams, D.H., Jurewicz, W.A.J., Jain, A.B. & Elias, E. (1987) Orthotopic liver transplantation: postoperative complications and their management. British Journal of Surgery, 74, 311.
  • Kohler, M. (1999) Thrombogenicity of prothrombin complex concentrates. Thrombosis Research, 95(4 Suppl. 1), S13S17.
  • Kralovics, R., Passamonti, F., Buser, A.S., Teo, S.S., Tiedt, R., Passweg, J.R., Tichelli, A., Cazzola, M., Skoda, R.C., Kralovics, R., Passamonti, F., Buser, A.S., Teo, S.-S., Tiedt, R., Passweg, J.R., Tichelli, A., Cazzola, M. & Skoda, R.C. (2005) A gain-of-function mutation of JAK2 in myeloproliferative disorders.[see comment]. New England Journal of Medicine, 352, 17791790.
  • Langley, P.G. & Williams, R. (1992) Physiological inhibitors of coagulation in fulminant hepatic failure. Blood Coagulation & Fibrinolysis, 3, 243248.
  • Leebeek, F.W.G., Kluft, C., Knot, E.A.R., De Maat, M.P.M. & Wilson, J.H.P. (1991) A shift in balance between profibrinolytic and antifibrinolytic factors causes enhance fibrinolysis in cirrhosis. Gastroenterology, 101, 13821390.
  • Levi, M., Toh, C.H., Thachil, J. & Watson, H.G. (2009) Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Journal of Haematology, 145, 2433.
  • Levine, R.L., Wadleigh, M., Cools, J., Ebert, B.L., Wernig, G., Huntly, B.J., Boggon, T.J., Wlodarska, I., Clark, J.J., Moore, S., Adelsperger, J., Koo, S., Lee, J.C., Gabriel, S., Mercher, T., D’Andrea, A., Frohling, S., Dohner, K., Marynen, P., Vandenberghe, P., Mesa, R.A., Tefferi, A., Griffin, J.D., Eck, M.J., Sellers, W.R., Meyerson, M., Golub, T.R., Lee, S.J., Gilliland, D.G., Levine, R.L., Wadleigh, M., Cools, J., Ebert, B.L., Wernig, G., Huntly, B.J.P., Boggon, T.J., Wlodarska, I., Clark, J.J., Moore, S., Adelsperger, J., Koo, S., Lee, J.C., Gabriel, S., Mercher, T., D’Andrea, A., Frohling, S., Dohner, K., Marynen, P., Vandenberghe, P., Mesa, R.A., Tefferi, A., Griffin, J.D., Eck, M.J., Sellers, W.R., Meyerson, M., Golub, T.R., Lee, S.J. & Gilliland, D.G. (2005) Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell, 7, 387397.
  • Lewis, J.H., Bontempo, F.A., Awad, S.A., Kang, Y.G., Kiss, J.E., Ragni, M.V., Spero, J.A. & Starzl, T.E. (1989) Liver transplantation: intraoperative changes in coagulation factors in 100 first transplants. Hepatology, 9, 710714.
  • Lisman, T. & Leebeek, F.W. (2007) Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Digestive Surgery, 24, 250258.
  • Lisman, T., Leebeek, F.W., Mosnier, L.O., Bouma, B.N., Meijers, J.C., Janssen, H.L., Nieuwenhuis, H.K. & De Groot, P.G. (2001) Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis. Gastroenterology, 121, 131139.
  • Lisman, T., Adelmeijer, J., De Groot, P.G., Janssen, H.L.A. & Leebeek, F.W. (2006a) No evidence for an intrinsic platelet defect in patients with liver cirrhosis - studies under flow conditions. Journal of Thrombosis and Haemostasis, 4, 20702072.
  • Lisman, T., Bongers, T.N., Adelmeijer, J., Janssen, H.L.A., Maat, M.P.Md., Groot, P.Gd. & Leebeek, F.W.G. (2006b) Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology, 44, 5361.
  • Lodge, J.P.A. (2004) Hemostasis in liver resection surgery. Seminars in Hematology, 41, 7075.
  • Lok, A.S.F., Ghany, M.G., Goodman, Z.D., Wright, E.C., Everson, G.T., Sterling, R.K., Everhart, J.E., Lindsay, K.L., Bonkovsky, H.L., Di Bisceglie, A.M., Lee, W.M., Morgan, T.R., Dienstag, J.L., Morishima, C. & Group, H.-C.T. (2005) Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort. Hepatology, 42, 282292.
  • Mannucci, P.M. (2006) Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? No. Journal of Thrombosis and Haemostasis, 4, 721723.
  • Mannucci, P.M., Canciani, M.T., Forza, I., Lussana, F., Lattuada, A. & Rossi, E. (2001) Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood, 98, 27302735.
  • Marra, F., Grandaliano, G., Valente, A.J. & Abboud, H.E. (1995) Thrombin stimulates proliferation of liver fat-storing cells and expression of monocyte chemotactic protein-1: potential role in liver injury. Hepatology, 22, 780787.
  • Martinez, J., MacDonald, K. & Palascak, J. (1983) The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains. Blood, 61, 11961202.
  • McGill, D.B., Rakela, J., Zinsmeister, A.R. & Ott, B.J. (1990) A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology, 99, 13961400.
  • McHutchinson, J.G., Dusheiko, G., Shiffman, M.L., Rodrigues-Torres, M., Sigal, S., Bourliere, M., Berg, T., Gordon, S.C., Campbell, F.M., Theodore, D., Blackman, N., Jenkins, J.M. & Afdhal, M.H. (2007) Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C. New England Journal of Medicine, 357, 22272236.
  • McMahon, C., Abu-Elmagd, K., Bontempo, F.A., Kant, J.A. & Swerdlow, S.H. (2007) JAK2 V617F mutation in patients with catastrophic intra-abdominal thromboses. American Journal of Clinical Pathology, 127, 736743.
  • McVay, P. & Toy, P. (1991) Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion, 31, 164171.
  • Montalto, P., Vlachogiannakos, J., Cox, D.J., Pastacaldi, S., Patch, D. & Burroughs, A.K. (2002) Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. Journal of Hepatology, 37, 463470.
  • Montero, J.L., Pozo, J.C., Barrera, P., Fraga, E., Costán, G., Domínguez, J.L., Muntané, J., Rodriguez-Ariza, A., Pleguezuelo, M., Rufián, S., López-Cillero, P. & De La Mata, M. (2006) Treatment of Refractory Cholestatic Pruritus With Molecular Adsorbent Recirculating System (MARS). Transplantation Proceedings, 38, 25112513.
  • Morath, C., Miftari, N., Dikow, R., Hainer, C., Zeier, M., Morgera, S., Weigand, M.A., Schwenger, V., Morath, C., Miftari, N., Dikow, R., Hainer, C., Zeier, M., Morgera, S., Weigand, M.A. & Schwenger, V. (2008) Sodium citrate anticoagulation during sustained low efficiency dialysis (SLED) in patients with acute renal failure and severely impaired liver function. Nephrology Dialysis Transplantation, 23, 421422.
  • Murray, K.F. & Carithers, R.L. (2005) AASLD Practice Guidelines: evaluation of the patient for Liver Transplantation. Hepatology, 41, 126.
  • Nagamine, T., Ohtuka, T., Takehara, K., Arai, T., Takagi, H. & Mori, M. (1996) Thrombocytopenia associated with hepatitis C viral infection. Journal of Hepatology, 24, 135140.
  • Neuberger, J., Gimson, A., Davies, M., Akyol, M., O’Grady, J., Burroughs, A. & Hudson, M., for the Liver Advisory Group, UK Blood and Transplant (2008) Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut, 57: 252257.
  • Northup, P.G., McMahon, M.M., Ruhl, A.P., Altshuler, S.E., Volk-Bednarz, A., Caldwell, S.H. & Berg, C.L. (2006) Coagulopathy does not fully protect hospitalised cirrhosis patients from peripheral venous thromboembolism. American Journal of Gastroenterology, 101, 15241528.
    Direct Link:
  • Northup, P.G., Sundaram, V., Fallon, M.B., Reddy, K.R., Balogun, R.A., Sanyal, A.J., Anstee, Q.M., Hoffman, M.R., Ikuru, Y. & Caldwell, S., Group tCiLD (2008) Hypercoagulation and thrombophilia in liver disease. Journal of Thrombosis and Haemostasis 6: 29.
  • O’Grady, J.G., Alexander, G.J.M., Halyllar, K.M. & Williams, R. (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology, 97, 439445.
  • Ogren, M., Bergqvist, D., Bjork, M., Acosta, S., Eriksson, H. & Sternby, N.H. (2006) Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World Journal of Gastroenterology, 12, 21152119.
  • Oka, K. & Tanaka, K. (1979) Intravascular coagulation in autopsy cases with liver disease. Thrombosis & Haemostasis, 42, 564570.
  • Palascak, J.E. & Martinez, J. (1977) Dysfibrinogenemia associated with liver disease. Journal of Clinical Investigation, 60, 8995.
  • Palsson, R. & Niles, J.L. (1999) Regional citrate anticoagulation in continuous venovenous haemofiltration in critically ill patients with a high risk of bleeding. Kidney International, 55, 19911997.
  • Papatheodoridis, G.V., Patch, D., Webster, G.J., Brooker, J., Barnes, E. & Burroughs, A.K. (1999) Infection and hemostasis in decompensated cirrhosis: a prospective study using thrombelastography. Hepatology, 29, 10851090.
  • Paramo, J.A., Rifon, J., Fernandez, J., Cuesta, B. & Rocha, E. (1991) Thrombin activation and fibrinolysis in patients with chronic liver disease. Blood Coagulation & Fibrinolysis, 2, 227230.
  • Patel, R.K. & Arya, R. (2005) Hepatology. In: Practical Haemostasis and Thrombosis (eds by D.O’Shaughnessy, M.Makris & D.Lillicrap), pp. 182189. Blackwell Publishing, Oxford, United Kingdom.
  • Patel, R.K., Lea, N.C., Heneghan, M.A., Westwood, N.B., Milojkovic, D., Thanigaikumar, M., Yallop, D., Arya, R., Pagliuca, A., Gäken, J., Wendon, J., Heaton, N.D. & Mufti, G.J. (2006) Prevalence of the Activating JAK2 Tyrosine Kinase Mutation V617F in the Budd-Chiari Syndrome. Gastroenterology, 130, 20312038.
  • Peck-Radosavljevic, M., Wichlas, M., Zacheri, J., Stiegler, G., Stohlawetz, P., Fuchsjager, M., Kreil, A., Metz-Schimmeri, S., Panzer, S., Steininger, R., Muhlbacher, F., Ferenci, P., Pidlich, J. & Gangi, A. (2000) Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood, 95, 795801.
  • Pereira, S.P., Langley, P.G. & Williams, R. (1996) The management of abnormalities of hemostasis in acute liver failure. Seminars in Liver Disease, 16, 403414.
  • Pereira, S.P., Rowbotham, D., Fitt, S., Shearer, M.J., Wendon, J. & Williams, R. (2005) Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease. Journal of Hepatology, 42, 365370.
  • Pernambuco, J.R.B., Langley, P.G., Hughes, R.D., Izumi, S. & Williams, R. (1993) Activation of the fibrinolytic system in patients with fulminant liver failure. Hepatology, 18, 13501356.
  • Piccinino, F., Sagnelli, E., Pasquale, G., Giusti, G., Battocchia, A., Bernardi, M., Bertolazzi, R., Bianchi, F.B., Brunelli, E., Budillon, G., Buscarini, L., Cargnel, A., Carrara, G., Carulli, N., Caruso, L., Cataldi, V., Celle, G., Chiandussi, L., Chiesa, L., Colombo, M., Coltorti, M., De Bac, C., Del Vecchio Blanco, C., Di Marco, G., Fiaccadori, F., Filippazzo, M.G., Fornari, F., Francavilla, A., Frezza, M., Gallo, V., Galvani, V., Givatto, T., Iannuzzi, C., Izzo, C.M., Le Moli, S., Longo, G., Magnani, G., Manai, M., Manenti, F., Manghisi, O., Manzillo, G., Marenco, G., Miglio, F., Molino, G., Mosca, P.G., Moschetta, R., Panella, C., Panichi, G., Parrilli, G., Pastore, G., Peluso, C., Picciotto, A., Pilleri, G., Pisi, E., Ponz de Leon, M., Rago, M., Raimondo, G., Realdi, G., Rizzetto, M., Rizzo, A., Ronchi, G., Rossi Fanelli, F., Ruggiero, G., Russo, N., Satta, A., Sansonno, D.E., Struglia, C., Tolentino, P., Tremolada, F., Trischitta, C., Verme, G., Viganò, P., Visco, G. & Zivelonghi, P. (1986) Complications following percutaneous liver biopsy: a multicentre retrospective study on 68 276 biopsies. Journal of Hepatology, 2, 165173.
  • Pihusch, R., Rank, A., Gohring, P., Pihusch, M., Hiller, M. & Beuers, U. (2002) Platelet function rather than plasmacytic coagulation explains hypercoagulable state in cholestatic liver disease. Journal of Hepatology, 37, 548555.
  • Pivalizza, E.G., Warters, R.D. & Gebhard, R. (2003) Desmopressin before liver transplantation. Canadian Journal of Anaesthesia, 50, 748749.
  • Planinsic, R.M., Van Der Meer, J., Testa, G., Grande, L., Candela, A., Porte, R.J., Ghobrial, R.M., Isoniemi, H., Schelde, P.B., Erhardtsen, E., Klintmalm, G., Emre, S., Planinsic, R.M., Van Der Meer, J., Testa, G., Grande, L., Candela, A., Porte, R.J., Ghobrial, R.M., Isoniemi, H., Schelde, P.B., Erhardtsen, E., Klintmalm, G. & Emre, S. (2005) Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease. [see comment]. Liver Transplantation, 11, 895900.
  • Polson, J. & Lee, W.M. (2005) AASLD position paper: the management of acute liver failure. Hepatology, 41, 11791197.
  • Porte, R.J., Bontempo, F.A., Knot, E.A.R., Lewis, J.H., Kang, Y.G. & Starzl, T.E. (1989) Systemic effects of tissue plasminogen activator-associated fibrinolysis and its relation to thrombin generation in orthotopic liver transplantation. Transplantation, 47, 978983.
  • Porte, R.J., Blauw, E., Knot, E.A.R., De Maat, M.P.M., De Ruiter, C., Bakker, C.M. & Terpstra, O.T. (1994) Role of the donor liver in the origin of platelet disorders and hyperfibrinolysis in liver transplantation. Journal of Hepatology, 21, 592600.
  • Porte, R.J., Molenaar, I.Q., Begliomini, B., Groenland, T.H., Januszkiewicz, A., Lindgren, L., Palareti, G., Hermans, J. & Terpstra, O.T. (2000) Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group. [see comment]. Lancet, 355, 13031309.
  • Poujol-Robert, A., Boëlle, P.-Y., Poupon, R. & Robert, A. (2004) Factor V Leiden as a risk factor for cirrhosis in chronic hepatitis C. Hepatology, 39, 11741175.
  • Primignani, M., Barosi, G., Bergamaschi, G., Gianelli, U., Fabris, F., Reati, R., Dell’Era, A., Bucciarelli, P. & Mannucci, P.M. (2006) Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. Hepatology, 44, 15281534.
  • Ramsay, M.A.E. (2006) Con: Antifibrinolytics are not safe and effective in patients undergoing liver transplantation. [comment]. Journal of Cardiothoracic & Vascular Anesthesia, 20, 891893.
  • Richards, E.M., Alexander, G.J., Calne, R.Y. & Baglin, T.P. (1997) Thrombocytopenia following liver transplantation is associated with platelet consumption and thrombin generation. British Journal of Haematology, 98, 315321.
  • Ring-Larsen, H. & Palazzo, U. (1981) Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types and prognosis. Gut, 22, 585591.
  • Robert, A. & Chazouilleres, O. (1996) Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio. Hepatology, 24, 13921394.
  • Roberts, H.R. & Cederbaum, A.I. (1972) The liver and blood coagulation: physiology and pathology. Gastroenterology, 63, 297319.
  • Robson, S.C., Kahn, D., Kruskal, J. , Bird, A.R. & Kirsch, R.E. (1993) Disordered hemostasis in extrahepatic portal hypertension. Hepatology, 18, 853857.
  • Rubin, M.H., Weston, M.J., Bullock, G., Roberts, J., Langley, P.G., White, Y.S. & Williams, R. (1977) Abnormal platelet function and ultrastructure in fulminany hepatic failure. The Quarterly Journal of Medicine, 183, 339352.
  • Salooja, N. & Perry, D.J. (2001) Thrombelastography. Blood Coagulation & Fibrinolysis, 12, 327337.
  • Sass, D.A. & Chopra, K.B. (2009) Portal hypertension and variceal hemorrhage. Medical Clinics of North America, 93, 837857.
  • Segal, J.B. & Dzik, W.H., network obotTmhct (2005) Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion, 45, 14131425.
  • Segal, H., Cottam, S., Potter, D. & Hunt, B.J. (1997) Coagulation and fibrinolysis in primary biliary cirrhosis compared with other liver disease and during orthotopic liver transplantation. Hepatology, 25, 683688.
  • Senzolo, M., Burra, P., Cholongitas, E. & Burroughs, A.K. (2006) New insights into the coagulopathy of liver disease and liver transplantation. World Journal of Gastroenterology, 12, 77257736.
  • Shami, V.M., Caldwell, S.H., Hespenheide, E.E., Arseneau, K.O., Bickston, S.J. & Macik, B.G. (2003) Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transplantation, 9, 138143.
  • Shearer, M.J. (1992) Vitamin K metabolism and nutriture. Blood Reviews, 6, 92104.
  • Soogard, K.K., Horvath-Puho, E., Groenbaek, H., Hepsen, P., Vilstrup, H. & SOrensen, H.T. (2009) Risk of venous thromboembolism in patients with liver disease: a nationwide population-based study. American Journal of Gastroenterology, 104, 96101.
  • Stahl, R.L., Duncan, A., Hooks, M.A., Henderson, J.M., Millikan, W.J. & Warren, W.D. (1990) A Hypercoagulable state follow orthotopic liver transplantation. Hepatology, 12, 553558.
  • Sterling, R.K., Lissen, E., Clumeck, N., Sola, R., Correa, M.C., Montaner, J., Sulkowski, M.S., Torriani, F.J., Dieterich, D.T., Thomas, D.L., Messinger, D., Nelson, M. & Investigators, A.C. (2006) Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology, 43, 13171325.
  • Sutedja, D.S., Wai, C.T., Teoh, K.F., Lee, H.L., DaCosta, M., Kaur, M., Lee, Y.M., Lee, K.H., Mak, K., Quak, S.H., Isaac, J., Lim, S.G. & Prabhakaran, K. (2004) Persistent thrombocytopenia in liver transplant patients. Transplantation Proceedings, 36, 23312333.
  • Tan, H.K., Yang, W.S., Chow, P., Lui, H.F., Choong, H.L., Wong, K.S., Tan, H.K., Yang, W.S., Chow, P., Lui, H.F., Choong, H.L. & Wong, K.S. (2007) Anticoagulation minimization is safe and effective in albumin liver dialysis using the molecular adsorbent recirculating system. Artificial Organs, 31, 193199.
  • Thalheimer, U., Triantos, C.K., Samonakis, D.N., Patch, D. & Burroughs, A.K. (2005) Infection, coagulation, and variceal bleeding in cirrhosis. Gut, 54, 556563.
  • The North Italian Endoscopic Club for the Study and Treatment of Esophageal varices (1988) Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. New England Journal of Medicine, 319, 983989.
  • Tripodi, A., Salerno, F., Chantarangkul, V., Clerici, M., Cazzaniga, M., Primignani, M. & Mannucci, P.M. (2005) Evidence of normal thrombin generation in cirrhosis despite abnormal coagulation tests. Hepatology, 41, 553558.
  • Tripodi, A., Primignani, M., Clerici, C., Dell’Era, A., Fabris, F., Salerno, F. & Mannucci, P.M. (2006) Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology, 44, 440445.
  • Tripodi, A., Mannucci, P.M., Tripodi, A. & Mannucci, P.M. (2007) Abnormalities of hemostasis in chronic liver disease: reappraisal of their clinical significance and need for clinical and laboratory research. [see comment]. Journal of Hepatology, 46, 727733.
  • Trotter, J.F., Brimhall, B., Arjal, R. & Phillips, C. (2004) Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation. Liver Transplantation, 10, 9951000.
  • Valla, D.C. (2004) Hepatic venous outflow tract obstruction etiopathogenesis: Asia versus the West. Journal of Gastroenterology and Hepatology, 19(s7), S204S211.
  • Valla, D.C. (2008) Thrombosis and anticoagulation in liver disease. Hepatology, 47, 13841393.
  • Valla, D.C. (2009) Primary Budd-Chiari Syndrome. Journal of Hepatology, 50, 195203.
  • Van Veen, J.J., Gatt, A. & Makris, M. (2008) Thrombin generation in routine clinical practice: are we there yet? British Journal of Haematology, 142, 889903.
  • Vincent, J.-L., Yagushi, A. & Pradier, O. (2002) Platelet function in sepsis. Critical Care Medicine, 30(Suppl), S313S317.
  • Violi, F., Basili, S., Ferro, D., Quintarelli, C., Alessandri, C., Cordova, C. & Group, C. (1996) Association between high values of D-dimer and Tissue-plasminogen activator activity and first gastrointestinal bleeding event in cirrhotic patients. Thrombosis & Haemostasis, 76, 177183.
  • Wanless, I.R., Liu, J.J. & Butany, J. (1995a) Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis). Hepatology, 21, 12321237.
  • Wanless, I.R., Wong, F., Blendis, L.M., Greig, P., Heathcote, E.J. & Levy, G. (1995b) Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology, 21, 12381247.
  • Warnaar, N., Molenaar, H.A., Colquhoun, S.D., Slooff, M.J.H., Sherwani, S., De Wolf, A.M. & Porte, R.J. (2008) Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: a systematic review. Journal of Thrombosis and Haemostasis, 6, 297302.
  • Weigert, A.L. & Schaffer, A.I. (1998) Uremic bleeding: pathogenesis and therapy. The American Journal of the Medical Sciences, 316, 94104.
  • Wiesner, R., Edwards, E., Freeman, R., Harper, A., Kim, R., Kamath, P., Kremers, W., Lake, J., Howard, T., Merion, R.M., Wolfe, R.A. & Krom, R. (2003) Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology, 124, 9196.
  • Wright, M., Goldin, R., Hellier, S., Knapp, S., Frodsham, A., Hennig, B., Hill, A., Apple, R., Cheng, S., Thomas, H. & Thursz, M. (2003) Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection. Gut, 52, 12061210.
  • Yanaga, K.M.D., Tzakis, A.G.M.D., Shimada, M.M.D., Campbell, W.E.M.D., Marsh, J.W.M.D., Stieber, A.C.M.D., Makowka, L.M.D.P.D., Todo, S.M.D., Gordon, R.D.M.D., Iwatsuki, S.M.D. & Starzl, T.E.M.D.P.D. (1989) Reversal of hypersplenism following orthotopic liver transplantation. Annals of Surgery, 210, 180183.
  • Youssef, W.I., Salazar, F., Dasarathy, S., Beddow, T. & Mullen, K.D. (2003) Role of fresh frozen plasma infusion in correction of coagulopathy of chronic liver disease: a dual phase study. American Journal of Gastroenterology, 98, 13911394.
    Direct Link:
  • Zakaria, N., Knisely, A., Portmann, B., Mieli-Vergani, G., Wendon, J., Arya, R., Devlin, J., Zakaria, N., Knisely, A., Portmann, B., Mieli-Vergani, G., Wendon, J., Arya, R. & Devlin, J. (2003) Acute sickle cell hepatopathy represents a potential contraindication for percutaneous liver biopsy. Blood, 101, 101103.